• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QSAR 模型预测合成大麻素对大麻素受体 1 的结合亲和力和依赖潜力。

QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids.

机构信息

School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.

Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Korea.

出版信息

Molecules. 2020 Dec 21;25(24):6057. doi: 10.3390/molecules25246057.

DOI:10.3390/molecules25246057
PMID:33371501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7767513/
Abstract

In recent years, there have been frequent reports on the adverse effects of synthetic cannabinoid (SC) abuse. SCs cause psychoactive effects, similar to those caused by marijuana, by binding and activating cannabinoid receptor 1 (CB1R) in the central nervous system. The aim of this study was to establish a reliable quantitative structure-activity relationship (QSAR) model to correlate the structures and physicochemical properties of various SCs with their CB1R-binding affinities. We prepared tetrahydrocannabinol (THC) and 14 SCs and their derivatives (naphthoylindoles, naphthoylnaphthalenes, benzoylindoles, and cyclohexylphenols) and determined their binding affinity to CB1R, which is known as a dependence-related target. We calculated the molecular descriptors for dataset compounds using an R/CDK (R package integrated with CDK, version 3.5.0) toolkit to build QSAR regression models. These models were established, and statistical evaluations were performed using the mlr and plsr packages in R software. The most reliable QSAR model was obtained from the partial least squares regression method via Y-randomization test and external validation. This model can be applied in vivo to predict the addictive properties of illicit new SCs. Using a limited number of dataset compounds and our own experimental activity data, we built a QSAR model for SCs with good predictability. This QSAR modeling approach provides a novel strategy for establishing an efficient tool to predict the abuse potential of various SCs and to control their illicit use.

摘要

近年来,有关合成大麻素(SC)滥用的不良影响的报道频繁出现。SC 通过与中枢神经系统中的大麻素受体 1(CB1R)结合并激活它,引起与大麻相似的精神活性作用。本研究旨在建立一个可靠的定量构效关系(QSAR)模型,以将各种 SC 的结构和物理化学性质与其 CB1R 结合亲和力相关联。我们制备了四氢大麻酚(THC)和 14 种 SC 及其衍生物(萘酰基吲哚、萘酰基萘、苯甲酰基吲哚和环己基苯酚),并测定了它们与 CB1R 的结合亲和力,CB1R 是一种与依赖性相关的靶标。我们使用 R/CDK(R 包与 CDK 集成,版本 3.5.0)工具包为数据集化合物计算了分子描述符,以构建 QSAR 回归模型。我们使用 R 软件中的 mlr 和 plsr 包建立并进行了统计评估。通过 Y 随机化测试和外部验证,从偏最小二乘回归方法中获得了最可靠的 QSAR 模型。该模型可在体内用于预测非法新型 SC 的成瘾特性。通过使用有限数量的数据集化合物和我们自己的实验活性数据,我们为 SC 建立了一个具有良好可预测性的 QSAR 模型。这种 QSAR 建模方法为建立一种有效的工具提供了一种新策略,以预测各种 SC 的滥用潜力并控制其非法使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/545771f43f32/molecules-25-06057-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/a3f4ab95a381/molecules-25-06057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/501db38490f7/molecules-25-06057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/43fdc1104dab/molecules-25-06057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/13f1576a4f34/molecules-25-06057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/531ddf13d8ed/molecules-25-06057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/a2233bf68087/molecules-25-06057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/e7563fd8cdfc/molecules-25-06057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/545771f43f32/molecules-25-06057-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/a3f4ab95a381/molecules-25-06057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/501db38490f7/molecules-25-06057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/43fdc1104dab/molecules-25-06057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/13f1576a4f34/molecules-25-06057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/531ddf13d8ed/molecules-25-06057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/a2233bf68087/molecules-25-06057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/e7563fd8cdfc/molecules-25-06057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2866/7767513/545771f43f32/molecules-25-06057-g008.jpg

相似文献

1
QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids.QSAR 模型预测合成大麻素对大麻素受体 1 的结合亲和力和依赖潜力。
Molecules. 2020 Dec 21;25(24):6057. doi: 10.3390/molecules25246057.
2
Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship model.合成大麻素:通过定量构效关系模型对大麻素受体1亲和力的计算机模拟预测
Toxicol Lett. 2016 Mar 14;245:1-6. doi: 10.1016/j.toxlet.2016.01.001. Epub 2016 Jan 12.
3
Apparent CB Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model.表观CB受体利莫那班亲和力估计:在小鼠体内三联模型中与四氢大麻酚和合成大麻素的联合作用
J Pharmacol Exp Ther. 2017 Jul;362(1):210-218. doi: 10.1124/jpet.117.240192. Epub 2017 Apr 25.
4
Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.通过基于构象搜索的 3D-QSAR 发现高亲和力大麻素受体配体。
Molecules. 2018 Aug 30;23(9):2183. doi: 10.3390/molecules23092183.
5
Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).使用基于指纹的人工神经网络(FANN-QSAR)进行配体生物活性预测。
Methods Mol Biol. 2015;1260:149-64. doi: 10.1007/978-1-4939-2239-0_9.
6
Focus on cannabinoids and synthetic cannabinoids.关注大麻素和合成大麻素。
Clin Pharmacol Ther. 2017 Feb;101(2):220-229. doi: 10.1002/cpt.563. Epub 2016 Dec 20.
7
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Variety: Δ-Tetrahydrocannabutol, the Butyl Homologue of Δ-Tetrahydrocannabinol.从药用品种中分离出对人类 CB1 受体具有高亲和力的大麻素:Δ-四氢大麻醇的丁基同系物Δ-四氢大麻丁醇。
J Nat Prod. 2020 Jan 24;83(1):88-98. doi: 10.1021/acs.jnatprod.9b00876. Epub 2019 Dec 31.
8
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.大麻素:奖赏、依赖及潜在神经化学机制——近期临床前数据综述
Psychopharmacology (Berl). 2003 Sep;169(2):115-34. doi: 10.1007/s00213-003-1485-z. Epub 2003 Jun 24.
9
An effort to discover the preferred conformation of the potent AMG3 cannabinoid analog when reaching the active sites of the cannabinoid receptors.努力发现强效 AMG3 大麻素类似物在到达大麻素受体的活性部位时的优先构象。
Eur J Med Chem. 2012 Jan;47(1):44-51. doi: 10.1016/j.ejmech.2011.10.015. Epub 2011 Oct 15.
10
Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations.使用源自半经验量子化学计算的描述符对一系列新型大麻素衍生物进行定量构效关系(QSAR)研究。
Bioorg Med Chem. 2009 Mar 15;17(6):2598-606. doi: 10.1016/j.bmc.2008.11.059. Epub 2008 Dec 3.

引用本文的文献

1
Evodiamine induces ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4.吴茱萸碱通过抑制TRIM26介导的GPX4稳定性诱导前列腺癌细胞发生铁死亡。
Chin Med. 2025 May 26;20(1):71. doi: 10.1186/s13020-025-01130-0.
2
Artificial intelligence approaches for anti-addiction drug discovery.用于抗成瘾药物发现的人工智能方法。
Digit Discov. 2025 May 13. doi: 10.1039/d5dd00032g.
3
The blood-to-plasma ratio and predicted GABA-binding affinity of designer benzodiazepines.设计苯二氮䓬类药物的血-浆比值和预测的 GABA 结合亲和力。

本文引用的文献

1
Maternal cannabis use in pregnancy and child neurodevelopmental outcomes.母亲在怀孕期间使用大麻与儿童神经发育结果。
Nat Med. 2020 Oct;26(10):1536-1540. doi: 10.1038/s41591-020-1002-5. Epub 2020 Aug 10.
2
Fluorinated CRA13 analogues: Synthesis, in vitro evaluation, radiosynthesis, in silico and in vivo PET study.氟化 CRA13 类似物:合成、体外评价、放射性合成、计算机模拟和体内 PET 研究。
Bioorg Chem. 2020 Jun;99:103834. doi: 10.1016/j.bioorg.2020.103834. Epub 2020 Apr 10.
3
Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.
Forensic Toxicol. 2022 Jul;40(2):349-356. doi: 10.1007/s11419-022-00616-y. Epub 2022 Mar 16.
4
QSAR models reveal new EPAC-selective allosteric modulators.定量构效关系模型揭示了新型的环磷腺苷效应元件结合蛋白(EPAC)选择性变构调节剂。
RSC Chem Biol. 2022 Aug 3;3(10):1230-1239. doi: 10.1039/d2cb00106c. eCollection 2022 Oct 5.
发现双重作用的阿片类配体和 TRPV1 拮抗剂作为治疗疼痛的新型治疗剂。
Eur J Med Chem. 2019 Nov 15;182:111634. doi: 10.1016/j.ejmech.2019.111634. Epub 2019 Aug 21.
4
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.疼痛医学中基于大麻的药物的最新进展
Pain Ther. 2019 Jun;8(1):41-51. doi: 10.1007/s40122-019-0114-4. Epub 2019 Feb 5.
5
Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CBR affinity.CRA13 及其类似物的氧化代谢物的合成:鉴定 CRA13 活性代谢物及其具有选择性 CBR 亲和力的类似物。
Bioorg Med Chem. 2018 Oct 1;26(18):5069-5078. doi: 10.1016/j.bmc.2018.09.007. Epub 2018 Sep 6.
6
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report.全球酒精、烟草和非法药物使用统计数据:2017 年现状报告。
Addiction. 2018 Oct;113(10):1905-1926. doi: 10.1111/add.14234. Epub 2018 Jun 4.
7
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS.屈大麻酚在治疗与HIV和艾滋病相关的体重减轻中的临床应用。
HIV AIDS (Auckl). 2016 Feb 10;8:37-45. doi: 10.2147/HIV.S81420. eCollection 2016.
8
Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship model.合成大麻素:通过定量构效关系模型对大麻素受体1亲和力的计算机模拟预测
Toxicol Lett. 2016 Mar 14;245:1-6. doi: 10.1016/j.toxlet.2016.01.001. Epub 2016 Jan 12.
9
Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.使用JWH-210后的不良反应——来自欧盟香料II+项目的系列病例
Drug Test Anal. 2016 Oct;8(10):1030-1038. doi: 10.1002/dta.1936. Epub 2016 Jan 15.
10
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.大麻素用于接受化疗的成年癌症患者的恶心和呕吐治疗。
Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464. doi: 10.1002/14651858.CD009464.pub2.